Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
Bitcoin Holders Withdraw $700 Million in $BTC off Exchanges in Impressive Vote of Confidence
-
McCormick Falls On Lower Quarterly Profit
-
Kala Pharmaceuticals Ascends 5% On Getting Fast Track Designation For Its KPI-012
-
Bitcoin Exchange Inflows Tap 6-Year Low as Investors Take Flight to Self-Custody
-
Bloomberg Strategist on $ETH vs $BTC: “Ethereum’s Upper Hand Could Be Enduring”